Interview: Amine Sekhri
How are health care authorities developing partnerships with private entities to develop a stronger and more competent sector?
AMINE SEKHRI: Algeria has a rather unique health care system in the region, supported by adequate health care policies that take into consideration the evolution of local epidemiology and the growing burden of non-communicable diseases. Recently, we have perceived with great satisfaction more openness from health care authorities towards various stakeholders, particularly the pharmaceutical industry. This was evident with the launch of several national plans, the signing of several memoranda of understanding and the implementation of a public-private partnership (PPP) framework. With respect to cancer, it is necessary to strengthen the national network of registries, producing more comprehensive and reliable local data.
There is also a clear willingness on the part of the government to develop a stronger pharmaceutical industry. Incentives already in place led to a substantial increase in commercial and industrial capacity, securing drug availability and reducing imports. These efforts should continue with the aim of further developing the pharmaceutical sector. One of the main considerations is to set up a framework that ensures predictability and visibility for companies, unleashing the sector’s potential, securing its sustainability and making it a key contributor to patients’ health.
In what ways can Algeria enhance its research and development (R&D) capacities?
SEKHRI: R&D in health care is valued not only from a scientific and medical perspective but also as an economic lever. R&D relies on political willingness, qualified human resources and infrastructure. Investments usually follow once these fundamentals are in place, some of which are already present in Algeria. Therefore, the country has the potential to become a regional centre of R&D. However, more focus must be made on strengthening the research governance model, as well as local competencies in different research areas. We need to continue investing in training and education initiatives, embedding the culture of research not only in Algerian academic and medical institutions but also in public and private companies. It is also important to connect these institutions, mutualising their resources and expertise, while also supporting research projects in line with health care priorities, such as cancer, diabetes and cardiovascular disease. This can also be achieved using the PPP model.
As clinical research is one of the most regulated activities in the industry, it is critical that regulations are harmonised with international standards and implemented in an efficient manner, thereby removing unnecessary administrative barriers to starting clinical trials. This will enhance the standing of Algeria in clinical research programmes at a global level.
How would you assess prices and the regulation of competition within the pharmaceuticals market?
SEKHRI: Pricing of medicine is strongly debated, especially in the current economic environment. A recent mechanism implemented by the authorities, based on multiple countries’ benchmarks, led to drug prices in Algeria being among the lowest in the region, with many pharmaceutical companies reacting positively.
Regulations on pricing need to also take into consideration that access is a multi-dimensional challenge; decreasing prices or delaying registration has a limited impact over time considering an ageing population’s increasing health care needs. We may need to be more flexible with our pricing and regulations in order to offer more suitable access solutions. It is also vital that all stakeholders collaborate together to establish health care technology assessment mechanisms, with dedicated resources to ensure an objective and transparent value determination of innovations, thereby ensuring that patients are treated with up-to-date technologies.
Read More from OBG
Focus Report: How Special Economic Zones are shaping Africa's industrial landscape
En Français As Africa embraces the transformative power of the African Continental Free Trade Area (AfCFTA), Special Economic Zones (SEZs) emerge as pivotal catalysts for regional economic growth.The impact of AfCFTA on SEZs on the continent is a key part of Africa’s growth, through improved market access, reduced trade barriers, and participation in regional value chains, which all enhance overall competitiveness. ESG considerations take centre stage, highlighting the imperative for …
Future growth: Sarah Al Amiri, Minister of State for Public Education and Advanced Technology, on developing technology talent
Interview: Sarah Al Amiri How can the intersection of advanced technology and public education influence economic growth? SARAH AL AMIRI: The UAE is building a digital, knowledge-based economy in line with its vision for the next 50 years. Advanced technology and education are fundamental pillars of this effort, and they are two of the government’s key priorities because of their power to transform the economy. Integrating advanced technology into public education equips students with the ne…
Focus Report: Exploring the role of women and youth in Africa's agriculture sector
En Français The last few years have seen marked developments in the dynamic landscape of African agriculture. The continent's cultivated land has expanded significantly since 2020, contributing to 52% of the global increase in cultivated area, with sub-Saharan Africa leading agricultural output growth. This report highlights the importance of transitioning to knowledge-based farming systems through initiatives from organisations seeking to achieve sustainable, inclusive and productive g…
“High-Level Discussions are Under Way to Identify How We Can Restructure Funding For Health Care Services”
Popular Sectors in Algeria
Popular Countries in Education
- Djibouti Education
- Nigeria Education
- Brunei Darussalam Education
- The Philippines Education
- Qatar Education
- UAE: Abu Dhabi Education
Recent Reports in Algeria